HSBC Holdings’s CytRx Corp CYTR Stock Holding History

HSBC Holdings’s Portfolio CYTR Stock Details CYTR Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q1	–	Sell	-2,785	Closed	-$6K	–	2870
2016 Q4	$6K	Buy	+2,785	New	+$8.19K	﹤0.01%	2715

Other funds holding CYTR

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Sabby Management Miami Beach, Florida $45.1M AUM 74.25% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Deutsche Bank Frankfurt Am Main Ge, Germany $303B AUM 30.15% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

HSBC Holdings's CYTR Position: Q1 2017 in Review

HSBC Holdings sold out of CytRx Corp (CYTR) in Q1 2017, closing a stake of 2,785 shares — an estimated $6K sold.

HSBC Holdings first reported a position in CYTR in Q4 2016 and held it in 1 quarter. The position peaked at $6K in Q4 2016. 69 funds tracked by Wall St. Rank hold CYTR as of Q1 2017.

HSBC Holdings reported no remaining CytRx Corp position as of Q1 2017 after selling out during the quarter.
HSBC Holdings sold 2,785 CytRx Corp shares in Q1 2017, an estimated $6K.
HSBC Holdings first reported a position in CytRx Corp in Q4 2016 and held it in 1 quarter.
HSBC Holdings's CytRx Corp position peaked at $6K in Q4 2016.
69 funds tracked by Wall St. Rank held CytRx Corp as of Q1 2017.

Based on HSBC Holdings's 13F filing for Q1 2017, filed 15 May 2017.